TY - JOUR T1 - Cyclodiode treatment of neovascular glaucoma secondary to Coats’ disease JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 690 LP - 691 DO - 10.1136/bjo.2006.097121 VL - 91 IS - 5 AU - D J de Silva AU - J L Brookes Y1 - 2007/05/01 UR - http://bjo.bmj.com/content/91/5/690.abstract N2 - Coats’ disease is characterised by an idiopathic retinal telangiectasia and exudative retinopathy, which may lead to retinal detachment.1–3 In 10% of eyes, neovascular glaucoma may occur and these eyes have been treated with primary enucleation.2,4 Although enucleation is an effective means of relieving severe ocular pain, it may remove an eye with some visual potential and postoperative complications occur in approximately 50% of cases.5,6 We report the first use of cyclodiode laser treatment in three consecutive patients with neovascular glaucoma secondary to advanced Coats’ disease. Three patients with neovascular glaucoma secondary to Coats’ disease presented to the Glaucoma Service at Moorfields Eye Hospital, London, UK, between 2004 and 2005. Table 1 summarises the characteristics of … ER -